Issue 41, 2022, Issue in Progress
From the journal:

RSC Advances

Retraction: MiR-320d suppresses the progression of breast cancer via lncRNA HNF1A-AS1 regulation and SOX4 inhibition

Shuai Shi,a   Xiaoling Hu,b   Jianpo Xu,c   Hong Liua  and  Libo Zou*a  

* Corresponding authors

a Reproductive Medicine Center of Jinhua People's Hospital, Biomedical Research Center of Zhejiang Normal University, Jinhua, China
E-mail: Shuai5189188@qq.com
Tel: +(86) 18258950539

b Department of Reproductive Endocrinology, Zhejiang University School of Medicine Affiliated Obstetrics and Gynecology Hospital, Hangzhou, China

c Life Sciences Institute of Zhejiang University, Hangzhou, China

Abstract

Retraction of ‘MiR-320d suppresses the progression of breast cancer via lncRNA HNF1A-AS1 regulation and SOX4 inhibition’ by Shuai Shi et al., RSC Adv., 2018, 8, 19196–19207, https://doi.org/10.1039/C8RA01200H.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D2RA90088B
Article type
Retraction
Submitted
26 Aug 2022
Accepted
26 Aug 2022
First published
20 Sep 2022
This article is Open Access
Creative Commons BY license

RSC Adv., 2022,12, 26639-26639

Permissions

Request permissions

Retraction: MiR-320d suppresses the progression of breast cancer via lncRNA HNF1A-AS1 regulation and SOX4 inhibition

S. Shi, X. Hu, J. Xu, H. Liu and L. Zou, RSC Adv., 2022, 12, 26639 DOI: 10.1039/D2RA90088B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements